Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma

Multiple myeloma (MM) is an aggressive and incurable disease for most patients, characterized by periods of treatment, remission and relapse. The introduction of new classes of drugs, such as proteasome inhibitors (PIs), has improved survival outcomes in these patient populations. The proteasome is...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambrosio, Francesca Alessandra, Costa, Giosuè, Gallo Cantafio, Maria Eugenia, Torcasio, Roberta, Trapasso, Francesco, Alcaro, Stefano, Viglietto, Giuseppe, Amodio, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919276/
https://www.ncbi.nlm.nih.gov/pubmed/36771100
http://dx.doi.org/10.3390/molecules28031438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919276/
https://www.ncbi.nlm.nih.gov/pubmed/36771100
http://dx.doi.org/10.3390/molecules28031438

Ejemplares similares